Your browser doesn't support javascript.
loading
Design and synthesis of ß-strand-fixed peptides inhibiting aggregation of amyloid ß-protein.
Tanaka, Fumiya; Shibata, Kana; Monobe, Yoko; Akagi, Ken-Ichi; Masuda, Yuichi.
Afiliação
  • Tanaka F; Graduate School of Bioresources, Mie University, 1577 Kurimamachiya-cho, Tsu 514-8507, Japan.
  • Shibata K; Graduate School of Bioresources, Mie University, 1577 Kurimamachiya-cho, Tsu 514-8507, Japan.
  • Monobe Y; National Institute of Biomedical Innovation, Health and Nutrition, Osaka 567-0085, Japan.
  • Akagi KI; National Institute of Biomedical Innovation, Health and Nutrition, Osaka 567-0085, Japan.
  • Masuda Y; Graduate School of Bioresources, Mie University, 1577 Kurimamachiya-cho, Tsu 514-8507, Japan. Electronic address: masuda@bio.mie-u.ac.jp.
Bioorg Med Chem ; 28(18): 115676, 2020 09 15.
Article em En | MEDLINE | ID: mdl-32828432
Aggregation of 42-residue amyloid ß-protein (Aß42) can be prevented by ß-sheet breaker peptides (BSBps) homologous to LVFFA residues, which are included in a ß-sheet region of Aß42 aggregates. To enhance the affinity of BSBps to the Aß42 aggregates, we designed and synthesized ß-strand-fixed peptides (BSFps) whose side chains were cross-linked by ring closing metathesis. Conformation analysis verified that the designed peptides could be fixed in ß-strand conformation. Among the synthesized pentapeptides, 1 and 12, whose side chains of 2nd and 4th residues were cross-linked, significantly inhibited the aggregation of Aß42. This suggested that ß-strand-fixation of BSBps could enhance their inhibitory activity against the Aß42 aggregation. However, pentapeptides 1 and 12 had little effect on morphology of Aß42 aggregates (fibrils) and neurotoxicity of Aß42 against SH-SY5Y cells.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Fármacos Neuroprotetores / Agregados Proteicos / Amiloide Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Fármacos Neuroprotetores / Agregados Proteicos / Amiloide Idioma: En Ano de publicação: 2020 Tipo de documento: Article